{"entity":{"type":"insider","cik":"0001285101","url":"/insider/0001285101","json_url":"/insider/0001285101.json","name":"SHANNON COLIN","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":60,"n_filings":15,"first":"2004-07-22","last":"2021-06-30","span_basis":"filed_date"},"name_variants":[{"name":"SHANNON COLIN","source":"filing","n_filings":15,"first_seen":"2004-07-22","last_seen":"2021-06-30"}],"transactions":[{"id":4768375,"accession":"0001104659-21-083604","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001104659-21-083604","line_url":"/filing/0001104659-21-083604","is_derivative":false,"issuer_cik":"0001285101","issuer_name":"PRA Health Sciences, Inc.","issuer_ticker":"PRAH","issuer_name_source":null,"issuer_url":"/issuer/0001285101","owner_cik":"0001285101","owner_name":"SHANNON COLIN","owner_display_name":"SHANNON COLIN","owner_url":"/insider/0001285101","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":442241.0,"shares_display":"442,241","price_per_share":168.7633421143675,"price_display":"168.76","price_state":"stated","total_value":74634069.18,"total_display":"74,634,069.18","total_whole":"74,634,069","shares_owned_after":114400.0,"shares_owned_after_display":"114,400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-17","filed_date":"2021-06-21","scope":"insider","n_lines":4},{"id":9223649,"accession":"0001104659-21-087297","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-087297","line_url":"/filing/0001104659-21-087297","is_derivative":false,"issuer_cik":"0001285101","issuer_name":"PRA Health Sciences, Inc.","issuer_ticker":"PRAH","issuer_name_source":null,"issuer_url":"/issuer/0001285101","owner_cik":"0001285101","owner_name":"SHANNON COLIN","owner_display_name":"SHANNON COLIN","owner_url":"/insider/0001285101","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8126.0,"shares_display":"8,126","price_per_share":166.57781196160474,"price_display":"166.58","price_state":"stated","total_value":1353611.3,"total_display":"1,353,611.30","total_whole":"1,353,611","shares_owned_after":47494.0,"shares_owned_after_display":"47,494","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-16","filed_date":"2021-06-30","scope":"insider","n_lines":3},{"id":4312224,"accession":"0001104659-21-082830","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001104659-21-082830","line_url":"/filing/0001104659-21-082830","is_derivative":false,"issuer_cik":"0001285101","issuer_name":"PRA Health Sciences, Inc.","issuer_ticker":"PRAH","issuer_name_source":null,"issuer_url":"/issuer/0001285101","owner_cik":"0001285101","owner_name":"SHANNON COLIN","owner_display_name":"SHANNON COLIN","owner_url":"/insider/0001285101","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":88045.0,"shares_display":"88,045","price_per_share":166.48894315406895,"price_display":"166.49","price_state":"stated","total_value":14658519.0,"total_display":"14,658,519.00","total_whole":"14,658,519","shares_owned_after":58730.0,"shares_owned_after_display":"58,730","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-16","filed_date":"2021-06-17","scope":"insider","n_lines":2},{"id":4312211,"accession":"0001104659-21-082830","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-21-082830","line_url":"/filing/0001104659-21-082830","is_derivative":false,"issuer_cik":"0001285101","issuer_name":"PRA Health Sciences, Inc.","issuer_ticker":"PRAH","issuer_name_source":null,"issuer_url":"/issuer/0001285101","owner_cik":"0001285101","owner_name":"SHANNON COLIN","owner_display_name":"SHANNON COLIN","owner_url":"/insider/0001285101","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":143303.0,"shares_display":"143,303","price_per_share":168.30379964131944,"price_display":"168.30","price_state":"stated","total_value":24118439.4,"total_display":"24,118,439.40","total_whole":"24,118,439","shares_owned_after":55836.0,"shares_owned_after_display":"55,836","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-15","filed_date":"2021-06-17","scope":"insider","n_lines":2},{"id":4584237,"accession":"0001104659-21-076359","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-21-076359","line_url":"/filing/0001104659-21-076359","is_derivative":false,"issuer_cik":"0001285101","issuer_name":"PRA Health Sciences, Inc.","issuer_ticker":"PRAH","issuer_name_source":null,"issuer_url":"/issuer/0001285101","owner_cik":"0001285101","owner_name":"SHANNON COLIN","owner_display_name":"SHANNON COLIN","owner_url":"/insider/0001285101","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6470.0,"shares_display":"6,470","price_per_share":170.45,"price_display":"170.45","price_state":"stated","total_value":1102811.5,"total_display":"1,102,811.50","total_whole":"1,102,812","shares_owned_after":66754.0,"shares_owned_after_display":"66,754","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-01","filed_date":"2021-06-03","scope":"insider","n_lines":2},{"id":3043488,"accession":"0001104659-20-096111","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-20-096111","line_url":"/filing/0001104659-20-096111#line-1","is_derivative":false,"issuer_cik":"0001285101","issuer_name":"PRA Health Sciences, Inc.","issuer_ticker":"PRAH","issuer_name_source":null,"issuer_url":"/issuer/0001285101","owner_cik":"0001285101","owner_name":"SHANNON COLIN","owner_display_name":"SHANNON COLIN","owner_url":"/insider/0001285101","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6073.0,"shares_display":"6,073","price_per_share":102.88,"price_display":"102.88","price_state":"stated","total_value":624790.24,"total_display":"624,790.24","total_whole":"624,790","shares_owned_after":56927.0,"shares_owned_after_display":"56,927","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-13","filed_date":"2020-08-17","scope":"insider"},{"id":4221584,"accession":"0001104659-17-052248","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-17-052248","line_url":"/filing/0001104659-17-052248#line-1","is_derivative":false,"issuer_cik":"0001285101","issuer_name":"PRA Health Sciences, Inc.","issuer_ticker":"PRAH","issuer_name_source":null,"issuer_url":"/issuer/0001285101","owner_cik":"0001285101","owner_name":"SHANNON COLIN","owner_display_name":"SHANNON COLIN","owner_url":"/insider/0001285101","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400000.0,"shares_display":"400,000","price_per_share":74.85,"price_display":"74.85","price_state":"stated","total_value":29940000.0,"total_display":"29,940,000.00","total_whole":"29,940,000","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-14","filed_date":"2017-08-16","scope":"insider"},{"id":4221385,"accession":"0001104659-17-020366","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-17-020366","line_url":"/filing/0001104659-17-020366#line-2","is_derivative":false,"issuer_cik":"0001285101","issuer_name":"PRA Health Sciences, Inc.","issuer_ticker":"PRAH","issuer_name_source":null,"issuer_url":"/issuer/0001285101","owner_cik":"0001285101","owner_name":"SHANNON COLIN","owner_display_name":"SHANNON COLIN","owner_url":"/insider/0001285101","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":64.0,"price_display":"64.00","price_state":"stated","total_value":3200000.0,"total_display":"3,200,000.00","total_whole":"3,200,000","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-28","filed_date":"2017-03-30","scope":"insider"},{"id":4396644,"accession":"0001104659-17-011292","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-17-011292","line_url":"/filing/0001104659-17-011292#line-4","is_derivative":false,"issuer_cik":"0001285101","issuer_name":"PRA Health Sciences, Inc.","issuer_ticker":"PRAH","issuer_name_source":null,"issuer_url":"/issuer/0001285101","owner_cik":"0001285101","owner_name":"SHANNON COLIN","owner_display_name":"SHANNON COLIN","owner_url":"/insider/0001285101","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":97253.0,"shares_display":"97,253","price_per_share":61.5,"price_display":"61.50","price_state":"stated","total_value":5981059.5,"total_display":"5,981,059.50","total_whole":"5,981,060","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-23","filed_date":"2017-02-23","scope":"insider"},{"id":4396634,"accession":"0001104659-17-011292","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-17-011292","line_url":"/filing/0001104659-17-011292#line-2","is_derivative":false,"issuer_cik":"0001285101","issuer_name":"PRA Health Sciences, Inc.","issuer_ticker":"PRAH","issuer_name_source":null,"issuer_url":"/issuer/0001285101","owner_cik":"0001285101","owner_name":"SHANNON COLIN","owner_display_name":"SHANNON COLIN","owner_url":"/insider/0001285101","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2747.0,"shares_display":"2,747","price_per_share":61.5,"price_display":"61.50","price_state":"stated","total_value":168940.5,"total_display":"168,940.50","total_whole":"168,941","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-21","filed_date":"2017-02-23","scope":"insider"},{"id":3074578,"accession":"0001104659-16-140889","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001104659-16-140889","line_url":"/filing/0001104659-16-140889#line-5","is_derivative":false,"issuer_cik":"0001285101","issuer_name":"PRA Health Sciences, Inc.","issuer_ticker":"PRAH","issuer_name_source":null,"issuer_url":"/issuer/0001285101","owner_cik":"0001285101","owner_name":"SHANNON COLIN","owner_display_name":"SHANNON COLIN","owner_url":"/insider/0001285101","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":82617.0,"shares_display":"82,617","price_per_share":51.58,"price_display":"51.58","price_state":"stated","total_value":4261384.86,"total_display":"4,261,384.86","total_whole":"4,261,385","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-08-22","filed_date":"2016-08-22","scope":"insider"},{"id":3074573,"accession":"0001104659-16-140889","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-16-140889","line_url":"/filing/0001104659-16-140889#line-4","is_derivative":false,"issuer_cik":"0001285101","issuer_name":"PRA Health Sciences, Inc.","issuer_ticker":"PRAH","issuer_name_source":null,"issuer_url":"/issuer/0001285101","owner_cik":"0001285101","owner_name":"SHANNON COLIN","owner_display_name":"SHANNON COLIN","owner_url":"/insider/0001285101","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19694.0,"shares_display":"19,694","price_per_share":51.4,"price_display":"51.40","price_state":"stated","total_value":1012271.6,"total_display":"1,012,271.60","total_whole":"1,012,272","shares_owned_after":82617.0,"shares_owned_after_display":"82,617","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-08-19","filed_date":"2016-08-22","scope":"insider"},{"id":3074568,"accession":"0001104659-16-140889","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-16-140889","line_url":"/filing/0001104659-16-140889#line-3","is_derivative":false,"issuer_cik":"0001285101","issuer_name":"PRA Health Sciences, Inc.","issuer_ticker":"PRAH","issuer_name_source":null,"issuer_url":"/issuer/0001285101","owner_cik":"0001285101","owner_name":"SHANNON COLIN","owner_display_name":"SHANNON COLIN","owner_url":"/insider/0001285101","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10822.0,"shares_display":"10,822","price_per_share":51.76,"price_display":"51.76","price_state":"stated","total_value":560146.72,"total_display":"560,146.72","total_whole":"560,147","shares_owned_after":102311.0,"shares_owned_after_display":"102,311","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-08-18","filed_date":"2016-08-22","scope":"insider"},{"id":2823763,"accession":"0001104659-16-104263","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-16-104263","line_url":"/filing/0001104659-16-104263#line-1","is_derivative":false,"issuer_cik":"0001285101","issuer_name":"PRA Health Sciences, Inc.","issuer_ticker":"PRAH","issuer_name_source":null,"issuer_url":"/issuer/0001285101","owner_cik":"0001285101","owner_name":"SHANNON COLIN","owner_display_name":"SHANNON COLIN","owner_url":"/insider/0001285101","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":77019.0,"shares_display":"77,019","price_per_share":42.26,"price_display":"42.26","price_state":"stated","total_value":3254822.94,"total_display":"3,254,822.94","total_whole":"3,254,823","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-03-08","filed_date":"2016-03-10","scope":"insider"},{"id":7526616,"accession":"0001285101-07-000002","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001285101-07-000002","line_url":"/filing/0001285101-07-000002","is_derivative":false,"issuer_cik":"0001003124","issuer_name":"PHARMACEUTICAL PRODUCT DEVELOPMENT INC","issuer_ticker":"PPDI","issuer_name_source":null,"issuer_url":"/issuer/0001003124","owner_cik":"0001285101","owner_name":"SHANNON COLIN","owner_display_name":"SHANNON COLIN","owner_url":"/insider/0001285101","role":"Officer (EVP, Global Clinical Ops)","role_mark":"O","role_mark_label":"Officer (EVP, Global Clinical Ops)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Global Clinical Ops","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9667.0,"shares_display":"9,667","price_per_share":35.129820006206685,"price_display":"35.13","price_state":"stated","total_value":339599.97,"total_display":"339,599.97","total_whole":"339,600","shares_owned_after":2867.0,"shares_owned_after_display":"2,867","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-05-04","filed_date":"2007-05-07","scope":"insider","n_lines":6},{"id":7115756,"accession":"0001285101-07-000001","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001285101-07-000001","line_url":"/filing/0001285101-07-000001","is_derivative":false,"issuer_cik":"0001003124","issuer_name":"PHARMACEUTICAL PRODUCT DEVELOPMENT INC","issuer_ticker":"PPDI","issuer_name_source":null,"issuer_url":"/issuer/0001003124","owner_cik":"0001285101","owner_name":"SHANNON COLIN","owner_display_name":"SHANNON COLIN","owner_url":"/insider/0001285101","role":"Officer (EVP, Global Clinical Ops)","role_mark":"O","role_mark_label":"Officer (EVP, Global Clinical Ops)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Global Clinical Ops","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":32500.0,"shares_display":"32,500","price_per_share":34.13843507692307,"price_display":"34.14","price_state":"stated","total_value":1109499.14,"total_display":"1,109,499.14","total_whole":"1,109,499","shares_owned_after":4221.0,"shares_owned_after_display":"4,221","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-02-09","filed_date":"2007-02-12","scope":"insider","n_lines":6},{"id":4253144,"accession":"0001285101-06-000003","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001285101-06-000003","line_url":"/filing/0001285101-06-000003","is_derivative":false,"issuer_cik":"0001003124","issuer_name":"PHARMACEUTICAL PRODUCT DEVELOPMENT INC","issuer_ticker":"PPDI","issuer_name_source":null,"issuer_url":"/issuer/0001003124","owner_cik":"0001285101","owner_name":"SHANNON COLIN","owner_display_name":"SHANNON COLIN","owner_url":"/insider/0001285101","role":"Officer (EVP, Global Clinical Ops)","role_mark":"O","role_mark_label":"Officer (EVP, Global Clinical Ops)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Global Clinical Ops","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":71167.0,"shares_display":"71,167","price_per_share":35.40222504812624,"price_display":"35.40","price_state":"stated","total_value":2519470.15,"total_display":"2,519,470.15","total_whole":"2,519,470","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-10-20","filed_date":"2006-10-23","scope":"insider","n_lines":5},{"id":1635579,"accession":"0001285101-05-000001","txn_seq":24,"anchor":"line-24","filing_url":"/filing/0001285101-05-000001","line_url":"/filing/0001285101-05-000001#line-24","is_derivative":false,"issuer_cik":"0001003124","issuer_name":"PHARMACEUTICAL PRODUCT DEVELOPMENT INC","issuer_ticker":"PPDI","issuer_name_source":null,"issuer_url":"/issuer/0001003124","owner_cik":"0001285101","owner_name":"SHANNON COLIN","owner_display_name":"SHANNON COLIN","owner_url":"/insider/0001285101","role":"Officer (EVP, Global Clinical Ops)","role_mark":"O","role_mark_label":"Officer (EVP, Global Clinical Ops)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Global Clinical Ops","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5200.0,"shares_display":"5,200","price_per_share":58.83,"price_display":"58.83","price_state":"stated","total_value":305916.0,"total_display":"305,916.00","total_whole":"305,916","shares_owned_after":19333.0,"shares_owned_after_display":"19,333","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-07-20","filed_date":"2005-07-21","scope":"insider"},{"id":1635578,"accession":"0001285101-05-000001","txn_seq":23,"anchor":"line-23","filing_url":"/filing/0001285101-05-000001","line_url":"/filing/0001285101-05-000001#line-23","is_derivative":false,"issuer_cik":"0001003124","issuer_name":"PHARMACEUTICAL PRODUCT DEVELOPMENT INC","issuer_ticker":"PPDI","issuer_name_source":null,"issuer_url":"/issuer/0001003124","owner_cik":"0001285101","owner_name":"SHANNON COLIN","owner_display_name":"SHANNON COLIN","owner_url":"/insider/0001285101","role":"Officer (EVP, Global Clinical Ops)","role_mark":"O","role_mark_label":"Officer (EVP, Global Clinical Ops)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Global Clinical Ops","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":58.45,"price_display":"58.45","price_state":"stated","total_value":292250.0,"total_display":"292,250.00","total_whole":"292,250","shares_owned_after":27466.0,"shares_owned_after_display":"27,466","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-07-20","filed_date":"2005-07-21","scope":"insider"},{"id":1635577,"accession":"0001285101-05-000001","txn_seq":22,"anchor":"line-22","filing_url":"/filing/0001285101-05-000001","line_url":"/filing/0001285101-05-000001#line-22","is_derivative":false,"issuer_cik":"0001003124","issuer_name":"PHARMACEUTICAL PRODUCT DEVELOPMENT INC","issuer_ticker":"PPDI","issuer_name_source":null,"issuer_url":"/issuer/0001003124","owner_cik":"0001285101","owner_name":"SHANNON COLIN","owner_display_name":"SHANNON COLIN","owner_url":"/insider/0001285101","role":"Officer (EVP, Global Clinical Ops)","role_mark":"O","role_mark_label":"Officer (EVP, Global Clinical Ops)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Global Clinical Ops","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4752.0,"shares_display":"4,752","price_per_share":58.8,"price_display":"58.80","price_state":"stated","total_value":279417.6,"total_display":"279,417.60","total_whole":"279,418","shares_owned_after":6148.0,"shares_owned_after_display":"6,148","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-07-20","filed_date":"2005-07-21","scope":"insider"},{"id":1635576,"accession":"0001285101-05-000001","txn_seq":21,"anchor":"line-21","filing_url":"/filing/0001285101-05-000001","line_url":"/filing/0001285101-05-000001#line-21","is_derivative":false,"issuer_cik":"0001003124","issuer_name":"PHARMACEUTICAL PRODUCT DEVELOPMENT INC","issuer_ticker":"PPDI","issuer_name_source":null,"issuer_url":"/issuer/0001003124","owner_cik":"0001285101","owner_name":"SHANNON COLIN","owner_display_name":"SHANNON COLIN","owner_url":"/insider/0001285101","role":"Officer (EVP, Global Clinical Ops)","role_mark":"O","role_mark_label":"Officer (EVP, Global Clinical Ops)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Global Clinical Ops","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2933.0,"shares_display":"2,933","price_per_share":58.85,"price_display":"58.85","price_state":"stated","total_value":172607.05,"total_display":"172,607.05","total_whole":"172,607","shares_owned_after":10900.0,"shares_owned_after_display":"10,900","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-07-20","filed_date":"2005-07-21","scope":"insider"},{"id":1635575,"accession":"0001285101-05-000001","txn_seq":20,"anchor":"line-20","filing_url":"/filing/0001285101-05-000001","line_url":"/filing/0001285101-05-000001#line-20","is_derivative":false,"issuer_cik":"0001003124","issuer_name":"PHARMACEUTICAL PRODUCT DEVELOPMENT INC","issuer_ticker":"PPDI","issuer_name_source":null,"issuer_url":"/issuer/0001003124","owner_cik":"0001285101","owner_name":"SHANNON COLIN","owner_display_name":"SHANNON COLIN","owner_url":"/insider/0001285101","role":"Officer (EVP, Global Clinical Ops)","role_mark":"O","role_mark_label":"Officer (EVP, Global Clinical Ops)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Global Clinical Ops","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2748.0,"shares_display":"2,748","price_per_share":58.76,"price_display":"58.76","price_state":"stated","total_value":161472.48,"total_display":"161,472.48","total_whole":"161,472","shares_owned_after":2100.0,"shares_owned_after_display":"2,100","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-07-20","filed_date":"2005-07-21","scope":"insider"},{"id":1635574,"accession":"0001285101-05-000001","txn_seq":19,"anchor":"line-19","filing_url":"/filing/0001285101-05-000001","line_url":"/filing/0001285101-05-000001#line-19","is_derivative":false,"issuer_cik":"0001003124","issuer_name":"PHARMACEUTICAL PRODUCT DEVELOPMENT INC","issuer_ticker":"PPDI","issuer_name_source":null,"issuer_url":"/issuer/0001003124","owner_cik":"0001285101","owner_name":"SHANNON COLIN","owner_display_name":"SHANNON COLIN","owner_url":"/insider/0001285101","role":"Officer (EVP, Global Clinical Ops)","role_mark":"O","role_mark_label":"Officer (EVP, Global Clinical Ops)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Global Clinical Ops","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1904.0,"shares_display":"1,904","price_per_share":58.81,"price_display":"58.81","price_state":"stated","total_value":111974.24,"total_display":"111,974.24","total_whole":"111,974","shares_owned_after":17429.0,"shares_owned_after_display":"17,429","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-07-20","filed_date":"2005-07-21","scope":"insider"},{"id":1635573,"accession":"0001285101-05-000001","txn_seq":18,"anchor":"line-18","filing_url":"/filing/0001285101-05-000001","line_url":"/filing/0001285101-05-000001#line-18","is_derivative":false,"issuer_cik":"0001003124","issuer_name":"PHARMACEUTICAL PRODUCT DEVELOPMENT INC","issuer_ticker":"PPDI","issuer_name_source":null,"issuer_url":"/issuer/0001003124","owner_cik":"0001285101","owner_name":"SHANNON COLIN","owner_display_name":"SHANNON COLIN","owner_url":"/insider/0001285101","role":"Officer (EVP, Global Clinical Ops)","role_mark":"O","role_mark_label":"Officer (EVP, Global Clinical Ops)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Global Clinical Ops","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1800.0,"shares_display":"1,800","price_per_share":58.87,"price_display":"58.87","price_state":"stated","total_value":105966.0,"total_display":"105,966.00","total_whole":"105,966","shares_owned_after":24533.0,"shares_owned_after_display":"24,533","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-07-20","filed_date":"2005-07-21","scope":"insider"},{"id":1635572,"accession":"0001285101-05-000001","txn_seq":17,"anchor":"line-17","filing_url":"/filing/0001285101-05-000001","line_url":"/filing/0001285101-05-000001#line-17","is_derivative":false,"issuer_cik":"0001003124","issuer_name":"PHARMACEUTICAL PRODUCT DEVELOPMENT INC","issuer_ticker":"PPDI","issuer_name_source":null,"issuer_url":"/issuer/0001003124","owner_cik":"0001285101","owner_name":"SHANNON COLIN","owner_display_name":"SHANNON COLIN","owner_url":"/insider/0001285101","role":"Officer (EVP, Global Clinical Ops)","role_mark":"O","role_mark_label":"Officer (EVP, Global Clinical Ops)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Global Clinical Ops","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1600.0,"shares_display":"1,600","price_per_share":58.89,"price_display":"58.89","price_state":"stated","total_value":94224.0,"total_display":"94,224.00","total_whole":"94,224","shares_owned_after":500.0,"shares_owned_after_display":"500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-07-20","filed_date":"2005-07-21","scope":"insider"},{"id":1635571,"accession":"0001285101-05-000001","txn_seq":16,"anchor":"line-16","filing_url":"/filing/0001285101-05-000001","line_url":"/filing/0001285101-05-000001#line-16","is_derivative":false,"issuer_cik":"0001003124","issuer_name":"PHARMACEUTICAL PRODUCT DEVELOPMENT INC","issuer_ticker":"PPDI","issuer_name_source":null,"issuer_url":"/issuer/0001003124","owner_cik":"0001285101","owner_name":"SHANNON COLIN","owner_display_name":"SHANNON COLIN","owner_url":"/insider/0001285101","role":"Officer (EVP, Global Clinical Ops)","role_mark":"O","role_mark_label":"Officer (EVP, Global Clinical Ops)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Global Clinical Ops","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":58.82,"price_display":"58.82","price_state":"stated","total_value":88230.0,"total_display":"88,230.00","total_whole":"88,230","shares_owned_after":14629.0,"shares_owned_after_display":"14,629","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-07-20","filed_date":"2005-07-21","scope":"insider"},{"id":1635570,"accession":"0001285101-05-000001","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0001285101-05-000001","line_url":"/filing/0001285101-05-000001#line-15","is_derivative":false,"issuer_cik":"0001003124","issuer_name":"PHARMACEUTICAL PRODUCT DEVELOPMENT INC","issuer_ticker":"PPDI","issuer_name_source":null,"issuer_url":"/issuer/0001003124","owner_cik":"0001285101","owner_name":"SHANNON COLIN","owner_display_name":"SHANNON COLIN","owner_url":"/insider/0001285101","role":"Officer (EVP, Global Clinical Ops)","role_mark":"O","role_mark_label":"Officer (EVP, Global Clinical Ops)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Global Clinical Ops","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1300.0,"shares_display":"1,300","price_per_share":58.84,"price_display":"58.84","price_state":"stated","total_value":76492.0,"total_display":"76,492.00","total_whole":"76,492","shares_owned_after":16129.0,"shares_owned_after_display":"16,129","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-07-20","filed_date":"2005-07-21","scope":"insider"},{"id":1635569,"accession":"0001285101-05-000001","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0001285101-05-000001","line_url":"/filing/0001285101-05-000001#line-14","is_derivative":false,"issuer_cik":"0001003124","issuer_name":"PHARMACEUTICAL PRODUCT DEVELOPMENT INC","issuer_ticker":"PPDI","issuer_name_source":null,"issuer_url":"/issuer/0001003124","owner_cik":"0001285101","owner_name":"SHANNON COLIN","owner_display_name":"SHANNON COLIN","owner_url":"/insider/0001285101","role":"Officer (EVP, Global Clinical Ops)","role_mark":"O","role_mark_label":"Officer (EVP, Global Clinical Ops)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Global Clinical Ops","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1133.0,"shares_display":"1,133","price_per_share":59.0,"price_display":"59.00","price_state":"stated","total_value":66847.0,"total_display":"66,847.00","total_whole":"66,847","shares_owned_after":26333.0,"shares_owned_after_display":"26,333","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-07-20","filed_date":"2005-07-21","scope":"insider"}],"collapsed":true,"next_cursor":"2005-07-20|1635569","ledger_fault":false,"count":{"value":60,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":60,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":60},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001613859","name":"PRA Health Sciences, Inc.","url":"/issuer/0001613859","role":"Director, Officer (President & CEO)","n_filings":10,"first_seen":"2016-03-10","last_seen":"2021-06-30"},{"type":"issuer","type_label":"ISSUER","cik":"0001003124","name":"PHARMACEUTICAL PRODUCT DEVELOPMENT INC","url":"/issuer/0001003124","role":"Officer (EVP, Global Clinical Ops)","n_filings":5,"first_seen":"2004-07-22","last_seen":"2007-05-07"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001285101","retrieved_at":"2026-08-24T05:09:15+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}